Stocks
Agios Pharmaceuticals (AGIO) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.73 | 1.83 | 1.83 | 1.99 | 1.70 | 1.49 | |||
| Changes by years, y/y, % | +58% | -33% | 0% | +9% | -15% | -0.4% | |||
Agios Pharmaceuticals. Debt/EBITDA
Agios Pharmaceuticals. Debt/EBITDA, changes, %
Agios Pharmaceuticals (AGIO) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 1.93 | 1.95 | 1.93 | 1.74 | 1.49 | 1.49 | ||
| Changes by years, y/y, % | +37% | +54% | -18% | -12% | -23% | |||
| Changes by quarters, q/q, % | -3% | +1% | -1% | -10% | -14% | |||
